Feasibility and safety profile of posterior retroperitoneoscopic adrenalectomy in high-risk patients

• Conditions: E27; Other disorders of adrenal gland

• Registration Number: DRKS00018793
• Lead Sponsor: Krankenhaus Reinbek St. Adolf-Stift

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2019-07-15
• Study Start: 2019-10-11
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 42

Inclusion Criteria

Retroperitoneoscopic adrenalectomy in hospital Reinbek from 2014 to 2018

Exclusion Criteria

No retroperitoneoscopic adrenalectomy in hospital Reinbek

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary endpoint is postoperative complications within 90 days of surgery.

Secondary Outcome Measures

Name	Time	Method
As a secondary endpoint, the size of the removed adrenal gland was evaluated in the histopathological examination immediately postoperatively.